Skip to main content
. 2014 Sep 5;55(9):608–614. doi: 10.4111/kju.2014.55.9.608

FIG. 3.

FIG. 3

Both groups showed a statistically significant improvement in the International Prostate Symptom Score (IPSS), overactive bladder symptom score (OABSS), and quality of life (QoL) score. However, a statistically significant difference was not observed between the two groups. Group A: tamsulosin 0.2 mg only. Group B: tamsulosin 0.2 mg+solifenacin 5 mg. *Statistically significant by time (p<0.05).